Literature DB >> 14631576

[Hypertensive heart disease and microangiopathy].

M Kelm1, B E Strauer.   

Abstract

Cardiac alterations in patients with arterial hypertension comprise the manifestation of stenosis in epicardial arteries, disease of coronary resistive vessels, prothrombotic changes and endothelial dysfunction, pronounced perivascular and interstitial fibrosis, left ventricular hypertrophy, dilatation of the left atrium, increased sympathetic drive and degeneration of aortic valve. These alterations leads to the major clinical manifestations of hypertensive heart disease, that are symptoms of reduced coronary conductance, left ventricular hypertrophy, diastolic and systolic dysfunction with or without left ventricular enlargement and arrhythmia. Different non-invasive and invase procedures are available for screening and follow up of patients with hypertensive heart disease. The primary therapeutic target is, apart from lowering blood pressure, to reverse cardiac manifestations of arterial hypertension using specific therapeutic algorithms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631576     DOI: 10.1007/s00108-003-0946-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  75 in total

1.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

Authors:  J Stamler; R Stamler; J D Neaton; D Wentworth; M L Daviglus; D Garside; A R Dyer; K Liu; P Greenland
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

Review 2.  Heterogeneity of coronary vasomotion.

Authors:  C P Tiefenbacher; W M Chilian
Journal:  Basic Res Cardiol       Date:  1998-12       Impact factor: 17.165

3.  Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X")

Authors:  D Opherk; G Schuler; K Wetterauer; J Manthey; F Schwarz; W Kübler
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

4.  Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension.

Authors:  Maurizio Galderisi; Silvana Cicala; Pio Caso; Luigi De Simone; Arcangelo D'Errico; Antonio Petrocelli; Oreste de Divitiis
Journal:  Am J Cardiol       Date:  2002-10-15       Impact factor: 2.778

5.  Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension.

Authors:  M Vogt; W Motz; S Scheler; B E Strauer
Journal:  Am J Cardiol       Date:  1990-04-03       Impact factor: 2.778

6.  Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.

Authors:  Michael Hecht Olsen; Kristian Wachtell; Kirstine L Hermann; Erik Frandsen; Harriet Dige-Petersen; Jens Rokkedal; Richard B Devereux; Hans Ibsen
Journal:  Am Heart J       Date:  2002-09       Impact factor: 4.749

7.  Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries.

Authors:  M N Papanicolaou; R M Califf; M A Hlatky; R A McKinnis; F E Harrell; D B Mark; B McCants; R A Rosati; K L Lee; D B Pryor
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

Review 8.  ACE-inhibitors and coronary microcirculation.

Authors:  B E Strauer; M Vogt; W Motz
Journal:  Basic Res Cardiol       Date:  1993       Impact factor: 17.165

9.  Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy.

Authors:  M Mundhenke; B Schwartzkopff; B E Strauer
Journal:  Virchows Arch       Date:  1997-10       Impact factor: 4.064

10.  Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy.

Authors:  M Iriarte; R Caso; N Murga; J M Faus; D Sagastagoitia; E Molinero; M López de Argumedo; J Boveda
Journal:  Am J Cardiol       Date:  1995-02-15       Impact factor: 2.778

View more
  3 in total

Review 1.  [Cardiovascular end organ impairment due to hypertension].

Authors:  C M Schannwell; S Steiner; M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

Review 2.  [The heart in hypertension].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

Review 3.  [Hypertension and cardiac failure].

Authors:  C M Schannwell; M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.